November 6, 2017
4G Clinical Named to Pharma Top Technology Solution Providers
WELLESLEY, Mass., Nov. 6, 2017 /PRNewswire/ -- 4G Clinical announced its recognition today as one of the top 20 pharma and life science technology providers of 2017 for its randomization and trial supply management RTSM solution, Prancer.
The award selection by industry technology experts is based on Prancer's use of natural language processing to transform an outdated process during study start-up. By reading and interpreting written RTSM specifications and understanding them, NLP technology enables 4G to build a deployable system in moments, with the click of a button.
"It's a great honor to select 4G Clinical as one of the top 20 most promising pharma and life science technology providers of 2017," said Jeevan George, Managing Editor of CIOReview. "In addition to NLP technology, 4G developed their RTSM using agile software methodologies on the latest technology stack to deliver unparalleled performance for their customers."
"We are thrilled to be acknowledged among the top technology solution providers making a measurable impact on the pharma and life sciences industry," says Dave Kelleher, CEO of 4G Clinical. "This award aligns with our commitment to get critical medications to market faster."
Published from Fremont, California, CIOReview is a print magazine that explores and understands the plethora of ways adopted by firms to execute the smooth functioning of their businesses. A distinguished panel comprising of CEOs, CIOs, IT VPs including CIOReview editorial board finalized the "20 Most Promising Pharma and Life Science Technology Solution Providers 2017" in the U.S. and shortlisted the best vendors and consultants.
For more info, visit www.cioreview.com
About 4G Clinical
4G Clinical is a full service RTSM company focused on simplifying and accelerating the drug development process. The company was founded in October, 2015, to develop a service offering centered around a 4th generation Randomization and Trial Supply Management (RTSM) system, Prancer. Headquartered in the heart of the Boston biotech corridor, in Wellesley, MA, 4G Clinical has facilities and staff located in the U.S. and Europe, and offers global expertise and advisory services to pharmaceutical companies and contract research organizations.
Tag(s): Press Releases
Ed Tourtellotte, 4G Clinical CTO was the founder of Tourtellotte Solutions, a clinical trials consulting and technology company (acquired by Bioclinica). Ed designed and built the world’s first configurable IRT in 2000, and also designed the clinical trial supply simulator tcVisualize as well as Trident IWR.
Related Blog Posts HeadlineView All Blog Posts
September 19, 2017
4G Clinical Named Finalist for 2017 Scrip AwardRead More
October 19, 2016
4G Clinical, A Clinical Trials Software Company, Raises $5 Million In Series A1 Financing Led by Schooner CapitalRead More
October 24, 2016